Publications by authors named "N Peled"

Claim this Profile
O
Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial Protocol.
Jacqueline V Aredo, Nir Peled, Edurne Arriola, Heather Wakelee, Myung-Ju Ahn

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic decoding of regional cortical vulnerability to drug-resistant epilepsy using 7T MRI.
Haixia Mao, Teppei Matsubara, Naoaki Tanaka, Noam Peled, Hana Farzaneh

Commun Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib.
N Peled, A Tufman, L V Sequist, G Pasello, Q Wang

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ictal MEG-EEG Study to Localize the Onset of Generalized Seizures: To See Beyond What Meets the Eye.
Valentina Gumenyuk, Oleg Korzyukov, Noam Peled, Patrick Landazuri, Olga Taraschenko

Brain Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes.
Belal Krayim, Walid Shalata, Jair Bar, Mor Moskovitz, Ofer Rotem, Nir Peled

Lung Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis